Rege Nephro
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $17M
Investors
- 26
About Rege Nephro
a. Rege Nephro, was founded in 2019 and operates out of Kyoto, Japan. The company focuses on developing regenerative medical products. Rege Nephro specializes in advanced regenerative technologies aimed at addressing various health and wellness challenges. The company’s core offerings encompass innovative solutions designed to enhance cellular regeneration and promote recovery in patients. These products serve various end-user segments, including healthcare providers, rehabilitation centers, and individual consumers seeking improved health outcomes. The company has strategically targeted markets in Japan and select regions in Asia, where it has established a robust client base focused on therapeutic interventions. Rege Nephro generates revenue through a combination of B2B partnerships and direct-to-consumer sales channels. The company’s business transactions typically involve healthcare institutions purchasing regenerative products for clinical applications, alongside retail sales to consumers interested in personal health enhancements. Pricing structures are established around individual product lines, which include flagship regenerative therapies marketed to both healthcare professionals and end-users. Through these channels, the company effectively reaches its target markets, ensuring a steady flow of revenue from both institutional clients and consumers seeking health solutions. The company plans to use the July 2026 funds to advance clinical preparation and development of its kidney disease treatment and regenerative medicine programs, while supporting future licensing efforts, research activities, and hiring.
Who invested in Rege Nephro
26 investors across 3 rounds
See all investors in Rege Nephro
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rege Nephro
Who invested in Rege Nephro?
Rege Nephro has 26 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rege Nephro raised?
Rege Nephro has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Rege Nephro last raise money?
Rege Nephro's most recent round on record is a Series B, in Oct 2024.
What does Rege Nephro do?
Rege Nephro is a biotechnology company.
Where is Rege Nephro headquartered?
Rege Nephro is headquartered in Kyoto, Japan.
Which VCs invest in companies like Rege Nephro?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Rege Nephro's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rege Nephro? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.